Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT00898118
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosed with refractory cytopenia
* Hypocellular bone marrow and normal karyotype
* Underwent stem cell transplantation (SCT) from an HLA identical (8/8) sibling, an HLA identical (10/10) relative, or an HLA identical or single allelic disparate unrelated donor
* Received a preparative regimen including either thiotepa or fludarabine phosphate
* Concurrently enrolled on EWOG-MDS-2006
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00898118
Study Brief:
Protocol Section:
NCT00898118